Summary

In France, there is a discernible and concerning rise in the prevalence of respiratory disorders, which is increasingly recognized as a public health challenge. This upsurge can be attributed to several contributing factors, including environmental pollution, occupational exposures, lifestyle choices, and an aging population. According to the European Respiratory Society, the half of the population of France suffers from recurrent respiratory problems; only three out of 10 French people consider that they are at high risk of developing a condition. According to the National Liberary of Meficine (NIH) report, the current prevalence of chronic obstructive pulmonary disease (COPD) in France is estimated to be 2.6 million and is predicted to increase to 2.8 million by 2025. As the burden of these conditions continues to rise globally, including in countries like France, the need for advanced respiratory care devices is becoming increasingly paramount. These devices, which encompass a wide range of technologies, from inhalers and nebulizers to oxygen concentrators and ventilators, play a pivotal role in managing and alleviating the symptoms associated with respiratory disorders, thereby enhancing the quality of life for affected individuals. The escalating demand for these devices is not only a response to the growing prevalence of respiratory disorders but also a reflection of the evolving healthcare landscape, where emphasis is being placed on the early diagnosis, effective management, and on-going care of these conditions. Furthermore, these devices are pivotal in reducing the burden on healthcare facilities and personnel, as they empower individuals to take charge of their respiratory health from the comfort of their own homes. This growing need for respiratory care devices has prompted innovations and advancements in the field, ensuring that patients have access to cutting-edge solutions that are tailored to their specific needs, thus paving the way for an improved standard of care and better outcomes for those living with respiratory disorders.

According to the research report "France Respiratory Care Devices Market Overview, 2028," published by Bonafide Research, the market was valued at more than USD 700 Million in 2022. As the number of respiratory disorders is increasing in the region, it is boosting the demand of respiratory care devices. A key driver of this expansion is the increased manufacturing of respiratory care devices, which has not only bolstered the domestic supply but has also enhanced the country's position as a reliable global supplier. This manufacturing growth can be attributed to several factors, including a commitment to innovation, a skilled workforce, and adherence to rigorous quality control standards, all of which have contributed to producing high-quality and technologically advanced respiratory devices. The demand for respiratory care devices in France has been further boosted by the incorporation of new technologies. The convergence of digital health solutions, telemedicine, and advanced monitoring and diagnostic tools has revolutionized the respiratory care landscape, making it more patient-centric, efficient, and effective. These technological advancements have improved patient management, allowing for more personalized and precise care, as well as remote monitoring and telehealth services, which are particularly relevant in the context of the COVID-19 pandemic. This growth in the respiratory care devices market aligns with France's commitment to delivering high-quality healthcare services and addressing the increasing burden of respiratory disorders. As the demand for these devices continues to rise, it not only benefits patients and healthcare providers but also solidifies France's position as a leader in the medical technology sector, contributing to advancements in patient care and respiratory health on a broader scale.

In France, the market for respiratory equipment is meticulously segmented based on product types into four distinct categories: therapeutic devices, monitoring devices, diagnostic devices, and consumables and accessories. Among these categories, therapeutic devices emerge as the dominant force, boasting a significant market share. This prominence can be attributed to the increasing prevalence of respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and sleep apnea in the country, which necessitates a broad spectrum of therapeutic solutions. Therapeutic devices encompass a wide range of equipment, including inhalers, nebulizers, and continuous positive airway pressure (CPAP) machines, which play a pivotal role in managing these conditions, thus driving their widespread adoption in the market. However, the monitoring and diagnostic devices also command a substantial share. Monitoring devices, such as pulse oximeters and spirometers, are crucial tools for tracking the vital parameters of patients with respiratory issues, offering healthcare professionals and patients real-time data for effective disease management. Diagnostic devices, including advanced imaging technologies and pulmonary function tests, facilitate accurate and timely diagnosis, a critical step in ensuring proper and targeted treatment. The consumables and accessories category adds another dimension to the market, as it encompasses essential components like masks, filters, and tubing, which are indispensable for the proper functioning of respiratory equipment. While this category may not dominate in terms of revenue, it plays a pivotal role in ensuring the uninterrupted and safe operation of respiratory devices, supporting the overall ecosystem.

The French market for respiratory equipment encompasses a wide array of disease indications, highlighting the broad scope and importance of these devices in addressing various respiratory conditions. Among the key disease indications, chronic obstructive pulmonary disease (COPD) emerges as a significant driver of the market. COPD, characterized by chronic bronchitis and emphysema, presents a substantial healthcare burden in France, necessitating an extensive range of therapeutic and monitoring devices to manage its chronic and progressive nature. This has led to a considerable market share for COPD-related equipment, including inhalers, nebulizers, and oxygen therapy solutions. Sleep apnea, another major player in the market, has gained increasing recognition in recent years, largely due to its potential health risks. It has fueled the demand for specialized devices like continuous positive airway pressure (CPAP) machines and other respiratory equipment used to treat sleep-disordered breathing, ensuring patients receive effective therapy and enjoy improved sleep quality. Asthma, a common respiratory condition, also significantly contributes to the market, with a variety of inhalers and nebulizers being essential tools for managing this condition. Infectious diseases, particularly in the context of respiratory infections such as COVID-19, have stimulated the demand for diagnostic and monitoring equipment. These technologies have played a crucial role in early detection, monitoring, and management of respiratory infections, further underscoring their substantial market presence. Additionally, the "other disease indications" category encompasses a wide range of respiratory ailments, including interstitial lung diseases, bronchiectasis, and various allergic respiratory conditions, collectively adding to the market's robustness.

In the French respiratory equipment market, the segmentation based on end users is indicative of the dynamic landscape of healthcare delivery in the country. It encompasses a diverse range of institutions and facilities, each playing a pivotal role in providing comprehensive respiratory care. Hospitals stand out as the predominant and established end user in this market, serving as a major player. These institutions, characterized by their extensive resources, specialized medical staff, and advanced infrastructure, cater to a broad patient population, making them central hubs for respiratory healthcare. Hospitals are equipped with a wide array of respiratory devices, including ventilators, oxygen delivery systems, and advanced monitoring equipment, to provide immediate and intensive care to patients with severe respiratory conditions. Their significant market share reflects their role as primary points of care for acute cases, setting the benchmark for excellence in respiratory care. Ambulatory Care Centers (ACCs) represent another influential segment in the market. These outpatient facilities offer specialized respiratory care and diagnostic services, catering to patients who require ongoing monitoring, diagnosis, and treatment but do not necessarily need the level of intervention provided by hospitals. ACCs are equipped with a range of monitoring and diagnostic devices to facilitate efficient and effective care delivery, contributing significantly to the market's growth. Their role in providing accessible and timely care aligns with the evolving trends in healthcare, emphasizing the importance of preventive and outpatient services. Home care settings are emerging as a noteworthy and progressive segment within the respiratory equipment market. This growth can be attributed to the increasing preference for healthcare delivery in the comfort of one's own home.

Considered in this report:
• Geography: France
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report:
• France Respiratory Care Devices market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product Type:
• Therapeutic Devices
• Monitoring Devices
• Diagnostic Devices
• Consumables and Accessories

By Disease Indication:
• Chronic Obstructive Pulmonary disease (COPD)
• Sleep Apnea
• Asthma
• Infectious Diseases
• Other Disease Indications

By End User:
• Hospitals
• Ambulatory Care Centers (ACCs)
• Home Care Settings
• Other End User

The approach of the report:
This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and list out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, and annual reports of companies, analyzing the government-generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers into regional aspects, tier aspects, age groups, and gender. Once we have primary data with us we started verifying the details obtained from secondary sources.

Intended audience:
This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to the Respiratory Care Devices industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.

ページTOPに戻る

Table of Contents